/

Empresas

HA

No verificado

HAYA Therapeutics, SA

Sobre qué escribimos

BiotecnologíaEventosFarmacéuticaMedicina - VariosSalud

5 Comunicados de prensa

Ver todos los comunicados de prensa

08/05/2025

Biotecnología

Salud

Farmacéutica

Medicina - Varios

Oncología

HAYA Therapeutics Raises $65 Million in Series A Funding to Deliver Precision RNA-Guided Medicines for Chronic and Age-Related Diseases

Fuente

HAYA Therapeutics, SA

Editor

1.00

0

02/05/2025

Eventos

Ciencia

Higiene alimentaria

Biotecnología

Salud

Medicina - Varios

Cardiología

Farmacéutica

HAYA Therapeutics to Present on RNA-Guided Regulatory Genome Platform at the Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)

Fuente

HAYA Therapeutics, SA

Editor

1.00

0

12/02/2025

Biotecnología

Higiene alimentaria

Medicina alternativa

Salud

Sanidad

Oncología

Ciencia

Medicina - Varios

Cardiología

Eventos

HAYA Therapeutics Awarded Innosuisse Certificate for Sustainable Growth and Funding to Advance Treatment for Aggressive Solid Tumors

Fuente

HAYA Therapeutics, SA

Editor

1.00

0

04/09/2024

Mercado laboral

Industria

Biotecnología

Farmacéutica

Salud

HAYA Therapeutics Announces Collaboration with Lilly to Discover Novel Regulatory Genome Targets for Obesity and Related Metabolic Conditions Using Proprietary RNA Platform

Fuente

HAYA Therapeutics, SA

Editor

1.00

0

18/07/2024

HAYA Therapeutics Appoints Former Roche Global Head of Operations Eric Adam, Ph.D. as Chief Operating Officer

Fuente

HAYA Therapeutics, SA

Editor

1.00

0

Seguidores

0

Compatibilidad

0